Ipsen
Michela McMullan, PhD, currently serves as VP and Global Head of New Products Strategy & Innovation at Ipsen, a position held since April 2020, following roles as Senior Director and Director in Global New Products & Oncology Strategy. Prior experience includes managing consulting roles at Navigant from April 2017 to April 2020, focusing on Life Science Strategy. Michela's career began as a Healthcare Analyst at GlobalData Healthcare between January 2016 and March 2017. Educational qualifications include an ongoing IMD Executive Program (2022-2024), a Certificate in MBA from The London School of Economics and Political Science (2021), a PhD in Medicinal and Pharmaceutical Chemistry from Trinity College Dublin (2012-2015), and a BSc in the same field from Trinity College Dublin (2008-2012).
This person is not in any teams
This person is not in any offices
Ipsen
22 followers
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.